description Johnson & Johnson (JNJ) Overview
Johnson & Johnson, traded under JNJ, is a large healthcare company focused on innovative medicines and medical technology. Its former consumer-health business was separated as Kenvue, so household consumer products should no longer be presented as a current core division. Johnson & Johnson's separation announcement confirms that change. A long record of dividend increases places the company among businesses commonly described as Dividend Kings.
It is relevant to investors researching established healthcare exposure and dividend-paying shares. The combination of medicines and medical devices distinguishes it from a company focused on only one of those areas. Its scale and payment history explain the income-investing interest, while future returns still depend on business performance and the price paid for the shares.
help Johnson & Johnson (JNJ) FAQ
Does Johnson & Johnson pay a reliable dividend?
Yes, Johnson & Johnson is famously known for consistently distributing dividends to shareholders and is a popular Dividend King. It has increased its dividend payout for over 60 consecutive years, maintaining a substantial market capitalization.
How did the Kenvue spin-off affect Johnson & Johnson?
In 2023, Johnson & Johnson spun off its consumer health division, which includes brands like Tylenol and Band-Aid, into a new publicly traded company called Kenvue. This move allowed JNJ to focus heavily on its higher-growth pharmaceutical and medical device sectors.
What are the main business segments of Johnson & Johnson?
JNJ generates its revenue through two primary sectors after the Kenvue separation: pharmaceuticals and medical devices. The company remains a diversified healthcare giant with a massive global footprint.
Is JNJ considered a defensive stock?
As a diversified healthcare company with steady cash flow and essential medical products, many analysts consider it a relatively stable blue-chip stock. Its long history of dividend growth provides a steady income stream for conservative investors.
explore Explore More
Reviews & Comments
Write a Review
Be the first to review
Share your thoughts with the community and help others make better decisions.
